MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment

Physics in Medicine and Biology

Volumn 57, Issue 2, 2012, Pages 535-545

  Mu, Zhaomei ^a   Ma, C M ^a   Chen, Xiaoming ^a   Cvetkovic, Dusica ^a   Pollack, Alan ^b   Chen, Lili ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; COMBINATION THERAPY; DOCETAXEL; FOCUSED ULTRASOUND; HIGH INTENSITY FOCUSED ULTRASOUND; IN-VIVO; LNCAP CELLS; MR SCANNERS; NUDE MICE; POST TREATMENT; PROSTATE CANCERS; TUMOR GROWTH; TUMOR VOLUMES;

MAMMALS; RADIOTHERAPY; TUMORS; ULTRASONIC TESTING; ULTRASONICS;

DISEASES;

DOCETAXEL; TAXOID;

ANIMAL; ARTICLE; COMPUTER ASSISTED SURGERY; DRUG EFFECT; DRUG SCREENING; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; TRANSPORT AT THE CELLULAR LEVEL; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; PROSTATIC NEOPLASMS; SURGERY, COMPUTER-ASSISTED; TAXOIDS; TREATMENT OUTCOME; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855588823     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/57/2/535     Document Type: Article

References (24)

1. Armstrong A J and George D J 2010 Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer Prostate Cancer Prostatic Dis. 13 10816
2. Bednarski M D, Lee J W, Callstrom M R and Li K C 1997 In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound Radiology 204 2638 (Pubitemid 27281743)
3. Cao W, Shiverick K T, Namiki K, Sakai Y, Porvasnik S, Urbanek C and Rosser C J 2008 Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation World J. Urol. 26 50916
4. Chen L, Ma C-M, Richardson T, Freedman G and Konski A 2009 Treatment of bone metastasis using MR guided focused ultrasound Med. Phys. 36 2486 (Abstract)
5. Chen L, Mu Z, Hachem P, Ma C-M, Wallentine A and Pollack A 2010 MR-guided focused ultrasound: enhancement of intratumoral uptake [3H]-docetaxel in vivo Phys. Med. Biol. 55 7399410
6. Dittmar K M, Xie J, Hunter F, Trimble C, Bur M, Frenkel V and Li K C 2005 Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience Radiology 235 5416 (Pubitemid 40571094)
7. Dromi S et al 2007 Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect Clin. Cancer Res. 13 27227 (Pubitemid 46788041)
8. Engels F K, Sparreboom A, Mathot R A and Verweij J 2005 Potential for improvement of docetaxel-based chemotherapy: a pharmacological review Br. J. Cancer 93 1737 (Pubitemid 41133202)
9. Frenkel V, Etherington A, Greene M, Quijano J, Xie J, Hunter F, Dromi S and Li K C 2006a Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure Acad. Radiol. 13 46979
10. Frenkel V and Li K C 2006b Potential role of pulsed-high intensity focused ultrasound in gene therapy Future Oncol. 2 1119
11. Hancock H A, Smith L H, Cuesta J, Durrani A K, Angstadt M, Palmeri M L, Kimmel E and Frenkel V 2009 Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism Ultrasound Med. Biol. 35 172236
12. Hanks G E, Hanlon A L, Schultheiss T E, Pinover W H, Movsas B, Epstein B E and Hunt M A 1998 Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions Int. J. Radiat. Oncol. Biol. Phys. 41 50110 (Pubitemid 28275077)
13. Hu Z et al 2007 Investigation of HIFU-induced anti-tumor immunity in a murine tumor model J. Transl. Med. 5 34
14. Jacob R, Hanlon A L, Horwitz E M, Movsas B, Uzzo R G and Pollack A 2004 The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer Cancer 100 53843 (Pubitemid 38124771)
15. Kennedy J E 2005 High-intensity focused ultrasound in the treatment of solid tumours Nat. Rev. Cancer 5 3217 (Pubitemid 40488637)
16. Ma C-M CL et al 2009 MR guided focused ultrasound for high risk and recurrent breast cancer WC, IFMBE Proc. 25/VI ed O Dssel and W C Schlegel (Heidelberg: Springer) pp 1403
17. Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon H K, Hanlon A L, Agrawal S and Pollack A 2008 Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo Prostate 68 599609 (Pubitemid 351614638)
18. Nelson J L et al 2002 Ultrasonically activated chemotherapeutic drug delivery in a rat model Cancer Res. 62 72803 (Pubitemid 36025250)
19. Petrylak D P et al 2004 Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N. Engl. J. Med. 351 151320 (Pubitemid 39315318)
20. Poff J A, Allen C T, Traughber B, Colunga J, Xie Z, Chen B J, Wood C, Waes V, Li K C and Frenkel V 2008 Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib Radiology 248 48591
21. Pollack A, Zagars G K, Antolak J A, Kuban D A and Rosen II 2002 Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial Int. J. Radiat. Oncol. Biol. Phys. 54 67785
22. Stoyanova R, Hachem P, Hensley H, Khor L Y, Mu Z, Hammond M E, Agrawal S and Pollack A 2007 Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo Int. J. Radiat. Oncol. Biol. Phys. 68 115160 (Pubitemid 47053953)
23. Tannock I F et al 2004 Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N. Engl. J. Med. 351 150212 (Pubitemid 39315317)
24. Yuh E L, Shulman S G, Mehta S A, Xie J, Chen L, Frenkel V, Bednarski M D and Li K C 2005 Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model Radiology 234 4317 (Pubitemid 40139913)